Barchart.com's Chart of the Day - CynergisTek
Related Stocks
 CTEK - Cynergis Tek Inc
SymLastChgPct
CTEK4.78+0.01+0.21%

The Barchart Chart of the Day belongs to the cyber security stock CynergisTek(CTEK). I found the stock buy sorting Barchart's Top Stocks to Own list first by the most frequent number of new highs in the last month, then I used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on / the stock gained 13.91%.

CynergisTek, Inc. provides cyber security and information management consulting in healthcare industry. It specializes in privacy, security, compliance and document management. The company's service includes risk assessment, technical security, baseline security, information security program assessment, print security, vulnerability, architecture, penetration testing, social engineering and phishing and riskSonar assessment tool. CynergisTek Inc., formerly known as Auxilio, Inc., is headquartered in Mission Viejo, CA.

CTEK

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

  • 100% technical buy signals
  • 18.90+ Weighted Alpha
  • 3.91% gain in the last year
  • Trend spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 14 new highs and up 19.65% in the last month
  • Relative Strength Index 71.31%
  • Technical support level at 4.68
  • Recently traded at 4.75 with a 50 day moving average of 4.08

Fundamental factors:

  • Market Cap $46 million
  • P/E 8.42
  • Revenue expected to be down .10% this year but up by 7.40% next year
  • Earnings estimated to decrease by 22.20% this year but increase again by 16.30% next year and continue to compound at an annual rate of 20.00% for the next 5 years
  • Wall Street analysts have issued 3 strong buy recommendations on the stock